微信小陈
微信小章| 产品名称： | Influenza A virus (H1N1) |
|---|---|
| 商品货号： | TS213806 |
| Classification： | Orthomyxoviridae, Influenzavirus A |
| Agent： | Influenza A virus (H1N1) |
| Strain： | A/California/07/2009 (H1N1)pdm09 |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen 0.5 mL per vial Clarified allantoic fluid from inoculated eggs |
| Storage Conditions： | -70°C or colder |
| Comments： | The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09 virus for use as a vaccine during the 2009-2010 influenza season. The US Food and Drug Administration recommended A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010-2011 influenza season. The World Health Organization recommended influenza A/California/07/2009 (H1N1)pdm09-like viruses for use as vaccines during the 2010 Southern Hemisphere and the 2010-2011 Northern Hemisphere influenza seasons. |
| Effect on Host： | Hemagglutinates turkey RBC |
| Recommended Host： | SPF chicken embryonated eggs, 9-11 days old |
| Growth Conditions： | Temperature: 35°C Recommendations for Infection: Inoculate SPF chicken embryonated eggs (intra-allantoic) at 9-11 days old. Dilute virus in D-PBS prior to inoculation. Incubation: 2 days at 35°C in a humidified, non-CO2 atmosphere. |
| Name of Depositor： | D Wentworth, CDC |
| Chain of Custody： | ATCC |
| Source： | Isolated from a human in California, USA on April 9, 2009. |
| References： | Influenza Research Database – Details for A/California/7/2009(H1N1) National Center for Immunization and Respiratory Diseases, CDC. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58(RR-10): 1-8, 2009. PubMed: 19713882 Fiore AE, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59(RR-8): 1-62, 2010. PubMed: 20689501 WHO recommendations on the composition of influenza virus vaccines |